Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 8,646 | 8,645 | 10,326 | 13,045 | 10,936 |
| Cost of Goods | 5,677 | 5,265 | 6,804 | 7,432 | 6,995 |
| Gross Profit | 2,969 | 3,380 | 3,522 | 5,613 | 3,941 |
| Operating Expenses | 8,528 | 6,982 | 8,690 | 12,557 | 9,446 |
| Operating Income | -4,882 | -3,337 | -4,364 | -6,512 | -4,510 |
| Interest Expense | 551 | 529 | 478 | 430 | 33 |
| Other Income | -19 | -5 | -43 | -5 | -73 |
| Pre-tax Income | -5,452 | -3,871 | -4,885 | -6,947 | -4,616 |
| Income Tax | 26 | 28 | 15 | -28 | 49 |
| Net Income Continuous | -5,478 | -3,899 | -4,900 | -6,919 | -4,665 |
| Net Income | $-5,478 | $-3,899 | $-4,900 | $-6,919 | $-4,665 |
| EPS Basic Total Ops | -625.00 | -450.00 | -575.00 | -825.00 | -575.00 |
| EPS Basic Continuous Ops | -625.40 | -451.38 | -579.63 | -835.78 | -565.87 |
| EPS Diluted Total Ops | -625.00 | -450.00 | -575.00 | -825.00 | -575.00 |
| EPS Diluted Continuous Ops | -625.40 | -451.38 | -579.63 | -835.78 | -565.87 |
| EBITDA(a) | $-4,619 | $-2,958 | $-4,019 | $-6,025 | $-4,275 |